“Response Rate After Modified Regime DHAP and Toxicity With Refractory and Relapsed Disease in Lymphoma Patients”. Life and Science, vol. 4, no. 4, Oct. 2023, p. 7, https://doi.org/10.37185/LnS.1.1.348.